<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><span ><strong><u>CARCINOMA OF PROSTATE</u></strong></span></p><p style="margin-left:0cm;text-align:justify;"><span >Ninety-five per  cent  of these  tumours  are adenocarcinomas.  The majority of men affected are aged between 65 and 85 years. The incidence increases with age. It is recommended that every male, 40 years and above, should have annual screening by Prostate Specific Antigen (PSA) tests and Digital Rectal Examination (DRE) since early detection is associated with better prognosis. The benefit or otherwise of screening should be discussed with patients.</span> <span >Patients with a family history of prostate cancer and should consider annual screening from 40 years and above with PSA and DRE. It is worth noting that not every hard prostate on DRE is malignant. Likewise a normal-feeling prostate does not exclude a malignancy. A prostatic biopsy is therefore necessary to establish a diagnosis.</span></p><h3 style="margin-left:0cm;">CAUSES</h3><ul><li>Ageing</li><li>Functional testes</li><li>Family history of prostate cancer, breast cancer, ovarian cancer</li><li>Race (more common in blacks)</li><li>High dietary fat intake</li></ul><h3 style="margin-left:0cm;">SYMPTOMS</h3><ul><li>Asymptomatic: prostate cancer may be present without symptoms in the early stage</li><li>Lower Urinary Tract Symptoms (LUTS) and IPSS</li><li>Retention of urine</li><li>Haematuria</li><li>General debility anorexia, weight loss, listlessness</li><li>Bone pain (commonly in the waist or limbs)</li><li>Paralysis in the lower limbs or inability to walk</li><li>Pathological Fracture</li><li>Impotence</li><li>Haemospermia</li><li>Tenesmus</li></ul><h3 style="margin-left:0cm;">SIGNS</h3><p><strong>On DRE clinical signs include;</strong></p><ul><li>Hard prostate gland with an irregular surface and edges</li><li>Obliterated median sulcus</li><li>Adherent rectal mucosa</li></ul><h3 style="margin-left:0cm;">Advanced or metastatic disease:</h3><ul><li>Anaemia</li><li>Uraemia</li><li>Wasting</li><li>Bone tenderness</li><li>Paraplegia</li><li>Pathological fracture</li></ul><h3 style="margin-left:0cm;">INVESTIGATIONS</h3><ul><li>FBC</li><li>Blood urea, electrolytes and creatinine</li><li>Prostate Specific Antigen (PSA)</li><li>Liver function tests</li><li>Abdominal and pelvic ultrasound</li><li>Transrectal Ultrasound (TRUS) of the prostate, if available</li><li>Transrectal needle biopsy of the prostate</li><li>TRUS-guided or finger-guided</li></ul><h3 style="margin-left:0cm;">TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>To relieve symptoms</li><li>To control complications</li><li>To achieve cure for early disease</li><li>To prevent local progression and metastases</li></ul><h3 style="margin-left:0cm;">Non-pharmacological treatment</h3><ul><li>Urethral catheterisation to relieve urinary retention where needed</li><li>Radical prostatectomy or radiotherapy, under specialist care, for early disease</li><li>Surgical castration (bilateral orchidectomy) for advanced disease</li></ul><h3 style="margin-left:0cm;">Pharmacological treatment</h3><p style="margin-left:0cm;"><span >Evidence Rating: [A]</span></p><ul><li>Pharmacological treatment of carcinoma of the prostate, which involves hormonal manipulation, which inhibits growth of the tumour by depriving it of androgens, is best carried out under specialist care.</li><li>The common drugs used in advanced prostate cancer therapy are:</li></ul><ol><li><span >Antiandrogens</span></li></ol><ul><li>Bicalutamide, oral, 50 mg daily (refer to specialist)</li></ul><h3 style="margin-left:0cm;">Or</h3><ul><li>Flutamide, oral, 250 mg 8 hourly(refer to specialist)</li></ul><ol><li><span >Oestrogen</span></li></ol><ul><li>Stilboestrol, oral, 2-5 mg daily (Avoid in clients with cardiovascular diseases), (refer to specialist)</li></ul><p style="margin-left:0cm;"> </p><ol><li><span >LHRH Analogues</span></li></ol><ul><li>Goserelin, SC, preferably in the abdominal wall (refer to specialist)</li></ul><h3 style="margin-left:0cm;">Or</h3><ul><li>Leuprolide acetate, IM, (refer to specialist)</li></ul><h3 style="margin-left:0cm;">And</h3><ul><li>Bisphosphonates and Fentanyl patches(refer to specialist)</li></ul><p> </p><h3 style="margin-left:0cm;">REFERRAL CRITERIA</h3><p><span >Refer all cases to a specialist centre for evaluation and management</span></p>
</body>
</html>
